Fludrocortisone Acetate Compounded Oral Suspension
BRIEFING
Fludrocortisone Acetate Compounded Oral Suspension. This proposal is based on the version of the monograph official as of December 1, 2021. Changes are proposed to add Antimicrobial Effectiveness Testing 〈51〉 information to the Beyond-Use Date section.
Additionally, minor editorial changes have been made to update the monograph to current USP style.
Please submit comments to CompoundingSL@usp.org.
(CMP: B. Groat)
Case ID—SUB-125